During the past decade, Hornsby (Northern Sydney Health) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hornsby (Northern Sydney Health)" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "Anavex Canada Ltd." with 1 trials as a collaborator, "Jay L. Friedland MD Prostate Cancer Research Fund" with 1 trials as a collaborator and "Southern Star Research Pty Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hornsby (Northern Sydney Health)" are "Alzheimer Disease" (2 trials), "Diabetes Mellitus Type 1" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Hornsby (Northern Sydney Health)" in a lesser frequency.

Most popular intervention types in "Hornsby (Northern Sydney Health)" are "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ANAVEX2-73" (1 trials), "Accelerated Hypofractionation Radiotherapy" (1 trials), "Extended Hypofractionation Radiotherapy" (1 trials), "GNbAC1" (1 trials) and "High dose ANAVEX2-73" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hornsby (Northern Sydney Health)" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hornsby (Northern Sydney Health)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hornsby (Northern Sydney Health), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hornsby (Northern Sydney Health), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".